Total Payments
$13,378
2024 Payments
$1,781
Companies
60
Transactions
553
Medicare Patients
5,359
Medicare Billing
$488,576
Payment Breakdown by Category
Food & Beverage$12,684 (94.8%)
Travel$570.51 (4.3%)
Education$123.42 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,684 | 545 | 94.8% |
| Travel and Lodging | $570.51 | 4 | 4.3% |
| Education | $123.42 | 4 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $2,422 | 51 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,166 | 61 | $0 (2024) |
| Inari Medical, Inc. | $979.18 | 14 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $823.14 | 42 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $756.36 | 73 | $0 (2024) |
| Boston Scientific Corporation | $564.51 | 19 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $553.85 | 24 | $0 (2024) |
| Medtronic, Inc. | $522.66 | 11 | $0 (2024) |
| Amgen Inc. | $517.85 | 28 | $0 (2024) |
| PFIZER INC. | $401.92 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,781 | 69 | Inari Medical, Inc. ($192.80) |
| 2023 | $2,577 | 91 | Inari Medical, Inc. ($786.38) |
| 2022 | $1,435 | 51 | Janssen Pharmaceuticals, Inc ($207.85) |
| 2021 | $827.62 | 39 | Janssen Pharmaceuticals, Inc ($224.46) |
| 2020 | $806.17 | 42 | Medtronic Vascular, Inc. ($163.71) |
| 2019 | $1,839 | 91 | Abbott Laboratories ($424.24) |
| 2018 | $2,703 | 92 | Abbott Laboratories ($1,238) |
| 2017 | $1,410 | 78 | Abbott Laboratories ($293.43) |
All Payment Transactions
553 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.33 | General |
| Category: Cardiovascular | ||||||
| 12/02/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE MVP VVCS 6-12F (Device) | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: DEVICES | ||||||
| 11/20/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/18/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/08/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $50.38 | General |
| Category: Cardiology | ||||||
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.12 | General |
| Category: Cardiovascular | ||||||
| 11/06/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.02 | General |
| Category: Cardiovascular | ||||||
| 10/30/2024 | Abbott Laboratories | DIAMONDBACK CORONARY (Device) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Vascular | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: DIABETES | ||||||
| 10/23/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $31.85 | General |
| Category: Not Applicable | ||||||
| 10/23/2024 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/16/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $4.78 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/14/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.06 | General |
| Category: Cardiovascular | ||||||
| 10/11/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Cardiology | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/27/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $35.63 | General |
| Category: Cardiology | ||||||
| 09/25/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $25.22 | General |
| Category: Cardiovascular | ||||||
| 09/09/2024 | Abbott Laboratories | ULTREON (Device) | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: Vascular | ||||||
| 09/04/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $159.53 | General |
| Category: VTE | ||||||
| 09/03/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 08/29/2024 | Abbott Laboratories | ULTREON (Device) | Food and Beverage | In-kind items and services | $3.01 | General |
| Category: Vascular | ||||||
| 08/28/2024 | Abbott Laboratories | ULTREON (Device) | Food and Beverage | In-kind items and services | $4.86 | General |
| Category: Vascular | ||||||
| 08/28/2024 | Abbott Laboratories | ULTREON (Device) | Food and Beverage | In-kind items and services | $1.76 | General |
| Category: Vascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,424 | 1,951 | $364,138 | $125,581 |
| 2022 | 16 | 1,253 | 1,748 | $316,428 | $111,809 |
| 2021 | 18 | 1,363 | 1,836 | $399,640 | $136,172 |
| 2020 | 19 | 1,319 | 1,750 | $363,543 | $115,014 |
Total Patients
5,359
Total Services
7,285
Medicare Billing
$488,576
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 144 | 281 | $61,820 | $27,609 | 44.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 128 | 143 | $62,205 | $20,232 | 32.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 157 | 238 | $36,414 | $16,386 | 45.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 105 | 150 | $33,750 | $15,039 | 44.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 64 | 64 | $47,936 | $9,644 | 20.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 77 | 110 | $16,830 | $7,223 | 42.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 37 | $11,211 | $5,391 | 48.1% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 22 | 23 | $28,474 | $4,960 | 17.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 58 | 60 | $5,245 | $3,260 | 62.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 316 | 453 | $7,072 | $2,990 | 42.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 193 | 261 | $17,487 | $2,933 | 16.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $6,802 | $2,508 | 36.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 30 | 30 | $6,960 | $2,482 | 35.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 13 | 13 | $10,543 | $2,055 | 19.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $4,200 | $1,533 | 36.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 17 | 17 | $5,066 | $789.16 | 15.6% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 16 | 17 | $1,241 | $314.27 | 25.3% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 20 | 21 | $882.00 | $229.95 | 26.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 166 | 248 | $37,944 | $17,185 | 45.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 108 | 161 | $36,225 | $16,178 | 44.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 87 | 95 | $41,325 | $15,498 | 37.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 92 | 177 | $38,940 | $15,073 | 38.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 79 | 149 | $22,797 | $8,871 | 38.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 58 | 59 | $43,658 | $8,369 | 19.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 13 | 26 | $12,688 | $4,782 | 37.7% |
About Dr. Arnold Ghitis, MD
Dr. Arnold Ghitis, MD is a Cardiovascular Disease healthcare provider based in Plantation, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790860310.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arnold Ghitis, MD has received a total of $13,378 in payments from pharmaceutical and medical device companies, with $1,781 received in 2024. These payments were reported across 553 transactions from 60 companies. The most common payment nature is "Food and Beverage" ($12,684).
As a Medicare-enrolled provider, Ghitis has provided services to 5,359 Medicare beneficiaries, totaling 7,285 services with total Medicare billing of $488,576. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Plantation, FL
- Active Since 10/25/2006
- Last Updated 03/10/2016
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1790860310
Products in Payments
- XARELTO (Drug) $1,143
- FLOWTRIEVER CATHETER, S (Device) $979.18
- ENTRESTO (Drug) $576.28
- BRILINTA (Drug) $547.25
- JARDIANCE (Drug) $467.19
- ELIQUIS (Drug) $463.68
- CRM-Research only (Device) $392.40
- AMPLATZER Occluders (Device) $363.12
- LifeVest (Device) $344.98
- Asahi Fielder coronary guide wire (Device) $301.49
- FFRct (Device) $292.25
- Confirm Rx (Device) $289.91
- Repatha (Biological) $287.39
- FARXIGA (Drug) $275.89
- UPTRAVI (Drug) $236.98
- RESONATE (Device) $234.02
- Corlanor (Drug) $230.46
- Resolute (Device) $214.42
- LEQVIO (Drug) $180.08
- REVEAL LINQ (Device) $169.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Plantation
Dr. Robert Singal, Md, MD
Cardiovascular Disease — Payments: $107,811
Cardiovascular Disease $107,811
Kathir Selvan Subramanian, Md, MD
Cardiovascular Disease — Payments: $46,612
Cardiovascular Disease $46,612
David Steiman, M.d, M.D
Cardiovascular Disease — Payments: $19,015
Cardiovascular Disease $19,015
Craig Hostig, Md, MD
Cardiovascular Disease — Payments: $18,606
Cardiovascular Disease $18,606
Jose Soler, Md, Facc, MD, FACC
Cardiovascular Disease — Payments: $16,803
Cardiovascular Disease $16,803
Mr. Frederick Chaleff, Md, MD
Cardiovascular Disease — Payments: $12,578
Cardiovascular Disease $12,578